Risk of ischemic stroke in patients with ovarian cancer: A nationwide population-based study

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Kuan, Ai Seon ^a,b   Teng, Chung Jen ^b,c   Wu, Hua Hsi ^a,b   Su, Vincent Yi Fong ^a,b   Chen, Yung Tai ^d   Chien, Sheng Hsuan ^a   Yeh, Chiu Mei ^a   Hu, Li Yu ^e   Chen, Tzeng Ji ^a,b   Tzeng, Cheng Hwai ^a   Liu, Chia Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Ischemic stroke; Ovarian cancer; Platinum; Population based study

Indexed keywords

PLATINUM; ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN ISCHEMIA; CANCER PATIENT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MIDDLE AGED; NATIONAL HEALTH INSURANCE; OVARY CANCER; RISK FACTOR; TAIWAN; AGE; AGED; COMPLICATION; INCIDENCE; METHODOLOGY; OVARIAN NEOPLASMS; PUBLIC HEALTH; REGRESSION ANALYSIS; STROKE; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRAIN ISCHEMIA; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OVARIAN NEOPLASMS; REGRESSION ANALYSIS; RESEARCH DESIGN; RISK FACTORS; STROKE; TAIWAN;

EID: 84899147039     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-12-53     Document Type: Article

References (37)

1. 1999-2010 cancer incidence and mortality data. apps.nccd.cdc.gov/uscs/.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
3. Landrum LM, Java J, Mathews CA, Lanneau GS, Copeland LJ, Armstrong DK, Walker JL. Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a gynecologic oncology group study. Gynecol Oncol 2013, 130:12-18. 10.1016/j.ygyno.2013.04.001, 23578540.
4. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology 2004, 62:2025-2030. 10.1212/01.WNL.0000129912.56486.2B, 15184609.
5. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985, 64:16-35.
6. Borowski A, Ghodsizad A, Gams E. Stroke as a first manifestation of ovarian cancer. J Neurooncol 2005, 71:267-269. 10.1007/s11060-004-1394-y, 15735915.
7. Sanderson A, Bonington SC, Carrington BM, Alison DL, Spencer JA. Cerebral metastasis and other cerebral events in women with ovarian cancer. Clin Radiol 2002, 57:815-819.
8. Universal health coverage in Taiwan. http://www.nhi.gov.tw/Resource/webdata/21717_1_20120808UniversalHealthCoverage.pdf.
9. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011, 20:236-242. 10.1002/pds.2087, 21351304.
10. Kim SG, Hong JM, Kim HY, Lee J, Chung PW, Park KY, Kim GM, Lee KH, Chung CS, Bang OY. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 2010, 41:798-801. 10.1161/STROKEAHA.109.571356, 20150545.
11. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood 2013, 122:1712-1723. 10.1182/blood-2013-04-460121, 23908465.
12. Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer 2013, 49:1404-1413. 10.1016/j.ejca.2012.10.021, 23146958.
13. Matsushita H, Kurabayashi T, Tomita M, Yamamoto Y, Aoki Y, Tanaka K. Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer. Gynecol Obstet Invest 2001, 51:274-276. 10.1159/000058064, 11408741.
14. Yokota N, Koizume S, Miyagi E, Hirahara F, Nakamura Y, Kikuchi K, Ruf W, Sakuma Y, Tsuchiya E, Miyagi Y. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer 2009, 101:2023-2029. 10.1038/sj.bjc.6605406, 2795428, 19904262.
15. Wang X, Wang E, Kavanagh JJ, Freedman RS. Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 2005, 3:25. 10.1186/1479-5876-3-25, 1182397, 15969748.
16. von Tempelhoff GF, Dietrich M, Niemann F, Schneider D, Hommel G, Heilmann L. Blood coagulation and thrombosis in patients with ovarian malignancy. Thromb Haemost 1997, 77:456-461.
17. Jovin TG, Boosupalli V, Zivkovic SA, Wechsler LR, Gebel JM. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer. Neurology 2005, 64:1944-1945. 10.1212/01.WNL.0000163850.07976.63, 15955949.
18. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006, 37:1663-1667. 10.1161/01.STR.0000226604.10877.fc, 16728686.
19. Chu CN, Chen SW, Bai LY, Mou CH, Hsu CY, Sung FC. Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study. Br J Cancer 2011, 105:1419-1423. 10.1038/bjc.2011.361, 3241541, 21915128.
20. Chen PC, Muo CH, Lee YT, Yu YH, Sung FC. Lung cancer and incidence of stroke: a population-based cohort study. Stroke 2011, 42:3034-3039. 10.1161/STROKEAHA.111.615534, 21903961.
21. Huang YS, Lee CC, Chang TS, Ho HC, Su YC, Hung SK, Lee MS, Chou P, Chang YH, Lee CC. Increased risk of stroke in young head and neck cancer patients treated with radiotherapy or chemotherapy. Oral Oncol 2011, 47:1092-1097. 10.1016/j.oraloncology.2011.07.024, 21852184.
22. Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005, 41:423-429. 10.1016/j.ejca.2004.11.013, 15691643.
23. Czaykowski PM, Moore MJ, Tannock IF. High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. J Urol 1998, 160:2021-2024. 10.1016/S0022-5347(01)62232-8, 9817314.
24. Ruiz MA, Marugan I, Estelles A, Navarro I, Espana F, Alberola V, San Juan L, Aznar J, Garcia-Conde J. The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients. Cancer 1989, 63:643-648. 10.1002/1097-0142(19890215)63:4<643::AID-CNCR2820630407>3.0.CO;2-J, 2492447.
25. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985, 42:296-300. 10.1159/000226049, 3875817.
26. Schilsky RL, Anderson T. Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med 1979, 90:929-931. 10.7326/0003-4819-90-6-929, 375794.
27. Manno EM. Magnesium sulphate and cerebral vasospasm. Lancet Neurol 2005, 4:329-330. 10.1016/S1474-4422(05)70080-6, 15907735.
28. Eguchi R, Fujimori Y, Ohta T, Kunimasa K, Nakano T. Calpain is involved in cisplatin-induced endothelial injury in an in vitro three-dimensional blood vessel model. Int J Oncol 2010, 37:1289-1296.
29. Periard D, Boulanger CM, Eyer S, Amabile N, Pugin P, Gerschheimer C, Hayoz D. Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke?. Stroke 2007, 38:1636-1638. 10.1161/STROKEAHA.106.479733, 17379819.
30. Yen T, Walsh JD, Pejler G, Berndt MC, Geczy CL. Cisplatin-induced platelet activation requires mononuclear cells: role of GMP-140 and modulation of procoagulant activity. Br J Haematol 1993, 83:259-269. 10.1111/j.1365-2141.1993.tb08281.x, 7681317.
31. Li SH, Chen WH, Tang Y, Rau KM, Chen YY, Huang TL, Liu JS, Huang CH. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg 2006, 108:150-156. 10.1016/j.clineuro.2005.03.008, 16412836.
32. Martin GG, Fernandez SP, Castro VS, Cueto OH, Acebal MR. Vertebral artery occlusion after chemotherapy. Stroke 2008, 39:e38. Author reply e39, 10.1161/STROKEAHA.107.503987, 18162617.
33. Provencio M, Bonilla F, Lacasta A, Espana P. Cerebral infarction after cisplatin-based chemotherapy. Postgrad Med J 1994, 70:525-526.
34. Seng S, Liu Z, Chiu SK, Proverbs-Singh T, Sonpavde G, Choueiri TK, Tsao CK, Yu M, Hahn NM, Oh WK, Galsky MD. Risk of venous thromboembolism in patients with cancer treated with cisplatin: a systematic review and meta-analysis. J Clin Oncol 2012, 30:4416-4426. 10.1200/JCO.2012.42.4358, 23150697.
35. Tsai SJ, Huang YS, Tung CH, Lee CC, Lee MS, Chiou WY, Lin HY, Hsu FC, Tsai CH, Su YC, Hung SK. Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study. Radiat Oncol 2013, 8:41. 10.1186/1748-717X-8-41, 3599927, 23448602.
36. Jagsi R, Griffith KA, Koelling T, Roberts R, Pierce LJ. Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol 2006, 24:2779-2785. 10.1200/JCO.2005.04.0014, 16702581.
37. De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009, 101:928-937. 10.1093/jnci/djp147, 19535773.